FindTrial
Sign In

Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome: Case Report and Rehabilitative Treatment

Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome: Case Report and Rehabilitative Treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017433
Enrollment
Unknown
Registered
2018-07-30
Start date
2018-08-14
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome

Interventions

Clinical observation group:functional training

Sponsors

Guangzhou Women and Children's Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1. Between 2017 and 2018, Genetic testing confirmed Hyperorbitinemia-hyperammonemia-Homocythrinuria Syndrome in Guangzhou Women and Children's Medical Center; 2. Aged 3-14years old.

Exclusion criteria

Exclusion criteria: 1. Severe liver failure (acute phase); 2. Failing to cooperate with the health examination; 3. Those who cannot express their promises, such as mental patients.

Design outcomes

Primary

MeasureTime frame
Gross Motor Function Measure;Liver function;Activity of Daily Living Scale;Modified Ashworth Scale;—

Countries

China

Contacts

Public ContactKaishou Xu

Guangzhou Women and Children's Medical Center

xksyi@126.com+86 13422250582

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026